Wogonin is a lipid of Polyketides (PK) class. Wogonin is associated with abnormalities such as Hyperlipidemia, Atherosclerosis, Inflammatory disorder, Dermatitis, Atopic and Ischemia. The involved functions are known as Inflammation, Regulation, luciferase activity, store-operated calcium entry and Transcriptional Activation. Wogonin often locates in Cytoplasmic matrix, Pore, Membrane, Protoplasm and Mitochondria. The associated genes with Wogonin are SGK1 gene, ORAI1 gene, STIM1 gene, P4HTM gene and BCL2 gene.
To understand associated biological information of Wogonin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Wogonin is suspected in Ischemia, Hyperlipidemia, Atherosclerosis, Inflammatory disorder, Dermatitis, Atopic and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Wogonin
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Seo CS and Shin HK | HPLC-PDA Method for Simultaneous Determination of Nine Marker Components in Banhasasim-Tang. | 2016 | J Chromatogr Sci | pmid:26354947 |
Lu H et al. | Wogonin inhibits the proliferation of myelodysplastic syndrome cells through the induction of cell cycle arrest and apoptosis. | 2015 | Mol Med Rep | pmid:26398525 |
Oche B et al. | Cryptotanshinone and wogonin up-regulate eNOS in vascular endothelial cells via ERα and down-regulate iNOS in LPS stimulated vascular smooth muscle cells via ERβ. | 2016 | Arch. Pharm. Res. | pmid:26481132 |
Qu JT et al. | Vasodilatory Effect of Wogonin on the Rat Aorta and Its Mechanism Study. | 2015 | Biol. Pharm. Bull. | pmid:26632179 |
Fu R et al. | Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1α signaling axis. | 2016 | Oncotarget | pmid:26735336 |
Yeh YC et al. | Acute lung injury induced by lipopolysaccharide is inhibited by wogonin in mice via reduction of Akt phosphorylation and RhoA activation. | 2016 | J. Pharm. Pharmacol. | pmid:26749510 |
Huang FM et al. | BisGMA-induced cytotoxicity and genotoxicity in macrophages are attenuated by wogonin via reduction of intrinsic caspase pathway activation. | 2016 | Environ. Toxicol. | pmid:26756871 |
Fajol A et al. | Fibroblast growth factor (Fgf) 23 gene transcription depends on actin cytoskeleton reorganization. | 2016 | FEBS Lett. | pmid:26878191 |
Wei CY et al. | Protective effect of wogonin on endotoxin-induced acute lung injury via reduction of p38 MAPK and JNK phosphorylation. | 2017 | Environ. Toxicol. | pmid:26892447 |
Khan S et al. | Wogonin attenuates diabetic cardiomyopathy through its anti-inflammatory and anti-oxidative properties. | 2016 | Mol. Cell. Endocrinol. | pmid:27013352 |